About - Abaxys Therapeutics

About Us

As biopharmaceutical company, we aim to accelerate the development of highly innovative programs with strong potential.

ABAXYS represents a new paradigm for Drug Discovery in Neuroscienses.

Our Mission & Vision

Build-up a ‘First-/Best -in-Class’ Innovative Portfolio in Human Metabolic and Neurodegenerative Diseases

ABAXYS Therapeutics aims to become a key player and first-choice partner in the area of human severe diseases. We want to contribute to the development of highly innovative therapeutic solutions for metabolic and neurodegenerative diseases

Our approach will significantly reduce the time-to-clinics of efficacious disease modifying therapies

Our Key Approach

Our strategy is based on a business model which uses the local and European top R&D ecosystem to deliver disruptive Preclinical packages contributing to High Value Pharma Therapeutic programs

Hit Identification

With our Data Mining approach, we are able to efficiently identify new Hits.

Lead Optimization

With our Big Data and Simulation approach, we are able to accelerate the Preclinical process (from 3-5 years in only 6 months) by replacing lab, in-vitro, in-vivo experience with in-sillico validation.

Animal Modeling

With our Bio-imaging approach, we do not have to kill the Animal Model to see the impact of a drug. Thus we are able to follow the evolution of the disease, see the impact of a molecule and better predict the efficacy in human.